Denmark | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 30 "Pharmaceutical products" from Denmark totalled $ 21 billion in 2023. Sales of commodity group 30 from Denmark went up by 5.6% compared to 2022: exports of commodity group 30 "Pharmaceutical products" went up by $ 1.11 billion (cumulative exports of commodity group 30 from Denmark amounted $19.8 billion in 2022)
Exports of commodity group 30 "Pharmaceutical products" amounted to 15.4% of total exports from Denmark (cumulative merchandise exports from Denmark totalled $ 136 billion in 2023). The share of commodity group 30 in total exports from Denmark increased by 0.114 p.p. compared to 2022 (it was 15.3% in 2022 and cumulative exports from Denmark were equal to $ 129 billion).
Where does Denmark export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Denmark in 2023:
- Special Categories with a share of 81% (17 billion US$)
- Netherlands with a share of 6.14% (1.29 billion US$)
- USA with a share of 3.03% (637 million US$)
- Germany with a share of 1.46% (308 million US$)
- Norway with a share of 1.07% (226 million US$)
- Sweden - 182 million US$
- Finland - 118 million US$
- Poland - 103 million US$
- Switzerland - 91 million US$
- Belgium - 88 million US$
Exports structure of 30 - Pharmaceutical products - from Denmark in 2023 represented by the following main commodity groups:
- 75% (15.7 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 22% (4.7 billion US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 1.18% (248 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.733% (154 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.403% (84 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.222% (46 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
The value of imports of commodity group 30 "Pharmaceutical products" to Denmark totalled $ 5.44 billion in 2023. Sales of commodity group 30 to Denmark decreased by 6.11% in value terms compared to 2022. imports of commodity group 30 "Pharmaceutical products" decreased by $ 354 million (the value of imports of commodity group 30 to Denmark was equal to $5.79 billion in 2022)
Imports of commodity group 30 "Pharmaceutical products" accounted for 4.3% of total import flow to Denmark (in 2023, total imports to Denmark amounted to $ 126 billion). The share of commodity group 30 in total imports to Denmark decreased by 0.255 p.p. compared to 2022 (it was 4.56% in 2022 and cumulative imports to Denmark were equal to $ 127 billion).
Where does Denmark import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Denmark in 2023:
- Special Categories with a share of 19.9% (1.08 billion US$)
- Germany with a share of 16.8% (914 million US$)
- Netherlands with a share of 8.53% (464 million US$)
- Sweden with a share of 6.78% (369 million US$)
- Czech Republic with a share of 6.73% (366 million US$)
- Belgium with a share of 5.25% (285 million US$)
- France with a share of 4.42% (240 million US$)
- USA with a share of 3.92% (213 million US$)
- Hungary with a share of 3.55% (193 million US$)
- Switzerland with a share of 2.88% (157 million US$)
Imports structure of 30 - Pharmaceutical products - to Denmark in 2023 represented by the following main commodity groups:
- 66% (3.64 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 24% (1.32 billion US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 4.21% (229 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 2.04% (111 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 1.86% (101 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.659% (35 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
